Patents by Inventor Han Chung Kelvin Chong

Han Chung Kelvin Chong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10517075
    Abstract: A method and a pharmaceutical composition for increasing wound healing in an individual in need thereof, the method comprising administering an angiopoietin like 4 (ANGPTL4) polypeptide or a therapeutically active fragment thereof.
    Type: Grant
    Filed: February 26, 2018
    Date of Patent: December 24, 2019
    Assignee: Nanyang Technological University
    Inventors: Nguan Soon Tan, Han Chung Kelvin Chong
  • Patent number: 10160803
    Abstract: The invention relates to the C-terminal fragment of angiopoietin-related protein 4 [cAngptl4] as a diagnostic marker for viral and bacterial pneumonia; anti-angiopoietin-related protein 4 therapeutic antibodies, and the use of anti-angiopoietin-related protein 4 antibodies in the treatment of viral and bacterial pneumonia.
    Type: Grant
    Filed: January 23, 2014
    Date of Patent: December 25, 2018
    Assignees: National University of Singapore, Nanyang Technological University
    Inventors: Vincent Tak Kwong Chow, Nguan Soon Tan, Liang Li, Ming Jie Tan, Han Chung Kelvin Chong
  • Publication number: 20180199327
    Abstract: A method and a pharmaceutical composition for increasing wound healing in an individual in need thereof, the method comprising administering an angiopoietin like 4 (ANGPTL4) polypeptide or a therapeutically active fragment thereof.
    Type: Application
    Filed: February 26, 2018
    Publication date: July 12, 2018
    Inventors: Nguan Soon Tan, Han Chung Kelvin Chong
  • Patent number: 9931371
    Abstract: A method and a pharmaceutical composition for increasing wound healing in an individual in need thereof, the method comprising administering an angiopoietin like 4 (ANGPTL4) polypeptide or a therapeutically active fragment thereof.
    Type: Grant
    Filed: July 3, 2013
    Date of Patent: April 3, 2018
    Assignee: Nanyang Technologies University
    Inventors: Nguan Soon Tan, Han Chung Kelvin Chong
  • Publication number: 20150368331
    Abstract: The invention relates to the C-terminal fragment of angiopoietin-related protein 4 [cAngptl4] as a diagnostic marker for viral and bacterial pneumonia; anti-angiopoietin-related protein 4 therapeutic antibodies, and the use of anti-angiopoietin-related protein 4 antibodies in the treatment of viral and bacterial pneumonia.
    Type: Application
    Filed: January 23, 2014
    Publication date: December 24, 2015
    Applicants: Nanyang Technological University, National University of Singapore
    Inventors: Vincent Tak Kwong Chow, Nguan Soon Tan, Liang Li, Ming Jie Tan, Han Chung Kelvin Chong
  • Publication number: 20150210758
    Abstract: An antibody that binds C terminal region of angiopoietin like 4 protein its use and methods of treating cancer with the same.
    Type: Application
    Filed: August 6, 2013
    Publication date: July 30, 2015
    Inventors: Julien Lescar, Yee Hwa Wong, Wei Min Edmond Chua, Nguan Soon Andrew Tan, Han Chung Kelvin Chong, Ming Jie Tan, Royston-Luke Huang
  • Publication number: 20150196616
    Abstract: A method and a pharmaceutical composition for increasing wound healing in an individual in need thereof, the method comprising administering an angiopoietin like 4 (ANGPTL4) polypeptide or a therapeutically active fragment thereof.
    Type: Application
    Filed: July 3, 2013
    Publication date: July 16, 2015
    Inventors: Nguan Soon Tan, Han Chung Kelvin Chong